Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Various Advanced Cancer × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 442 Rectal Neoplasms 248 Colonic Neoplasms 201 Pancreatic Neoplasms 168 Stomach Neoplasms 165 Esophageal Neoplasms 123 Neoplasm Metastasis 106 Breast Neoplasms 104 Head and Neck Neoplasms 84 Squamous Cell Carcinoma of Head and Neck 80 Neoplasms 78 Adenocarcinoma Of Esophagus 61 Esophageal Squamous Cell Carcinoma 53 Carcinoma, Hepatocellular 50 Adenocarcinoma 37 Nasopharyngeal Carcinoma 32 Cholangiocarcinoma 29 Anus Neoplasms 23 Keratosis, Actinic 22 Gastrointestinal Neoplasms 22 Carcinoma, Squamous Cell 22 Carcinoma, Non-Small-Cell Lung 22 Biliary Tract Neoplasms 22 Liver Neoplasms 20 Gallbladder Neoplasms 20 Bile Duct Neoplasms 19 Urinary Bladder Neoplasms 18 Parkinson Disease 4, Autosomal Dominant Lewy Body 16 Nasopharyngeal Neoplasms 15 Carcinoma 13

Interventions

Nivolumab 4 Ipilimumab 2 Fluorouracil 1 Cisplatin 1 BMS-986115 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡